Most Popular Stories

Share This Page

: SPY |  News, Ratings, and Charts

Investor Alert: Healthy Pause for Stock Market

This recent pullback very much looks like a “healthy pause” for the stock market as the S&P 500 (SPY) comes off recent highs. What is the cause of the pause? How long will it last? What happens afterwards? And how to make money in this market? Steve Reitmeister will answer all these questions and more in his latest market commentary below...

: GFI |  News, Ratings, and Charts

3 Gold Stocks to Buy Poised for Success

With expected interest rate cuts, surging gold jewelry demand, and ongoing geopolitical conflicts, gold prices have hit record highs this year. Thus, it could be wise to buy fundamentally sound gold stocks Centerra Gold (CGAU), Gold Fields (GFI), and Kinross Gold (KGC), which are well-poised for success. Keep reading…

: CHGG |  News, Ratings, and Charts

3 Internet Stocks Poised up for Rapid Growth in April

The internet industry thrives thanks to expanding usage, its transformative impact on work and communication globally, advancements in 5G, and its widespread integration into daily life. Hence, it could be wise to consider adding internet stocks ATRenew (RERE), Chegg (CHGG), and 1-800-FLOWERS.COM (FLWS) to one’s portfolio for growth. Read on...

: TXN |  News, Ratings, and Charts

TXN vs. INTC Earnings Alert - Which Chip Stock Will Surge Ahead?

Growing applications of chips across diverse end-use sectors and emerging digital technologies will shape the growth trajectory of the semiconductor industry and create several opportunities for industry players. So, let’s analyze Texas Instruments (TXN) and Intel (INTC) to determine which of these chip stocks will surge following their first-quarter earnings. Read more...

: SPY |  News, Ratings, and Charts

Updated 2024 Stock Market Outlook

The bull market continues to rage on with the S&P 500 (SPY) making new highs. That is the past...the question is what does the future hold? That is why 44 year investment veteran Steve Reitmeister provides this updated 2024 Stock Market Outlook to help you carve a path to outperformance the rest of the year. Read on below for the full story...

Top Stories


NASDAQ: GOOGL | Alphabet Inc. News, Ratings, and Charts

Will GOOGL and AMZN Reign Supreme Among Tech Stocks in 2024?

Amidst the ever-changing digital terrain and the ascent of artificial intelligence (AI), the future looks promising for tech behemoths Alphabet (GOOGL) and Amazon.com (AMZN). Yet, a pressing query looms: Can GOOGL and AMZN uphold their status as reigning tech stock champions this year? Let's delve deeper to uncover the answer...

NYSE: WDAY | Workday Inc. Cl A News, Ratings, and Charts

3 Software Buys Surging Toward April Success

The software industry has shown resilience, consistent growth, innovation, and adaptability to changing market demands and emerging technologies. Given the industry’s solid growth prospects, fundamentally strong software stocks Workday (WDAY), Akamai Technologies (AKAM), and Smartsheet (SMAR) could be ideal additions to your portfolio. Read on...

NASDAQ: TSLA | Tesla, Inc. News, Ratings, and Charts

Will TSLA and NIO Stocks Stage a Recovery in April?

Battery electric vehicle (BEV) makers are grappling with a demand slowdown, changing consumer preferences, chip shortages, a surge in demand for hybrid vehicles, and sales challenges. Amid this uncertain backdrop, will automakers Tesla, Inc. (TSLA) and NIO Inc. (NIO) stage a recovery? Let’s discuss...

NASDAQ: UTHR | United Therapeutics Corporation News, Ratings, and Charts

3 Promising Biotech Stocks Driving Weekly Gains

The biotech industry’s prospects appear promising due to government support, regulatory changes, innovative therapies, and a focus on personalized medicine. Therefore, investors could consider buying fundamentally strong biotech stocks such as United Therapeutics (UTHR), TRACON Pharmaceuticals (TCON), and Corcept Therapeutics (CORT). Read more...

NASDAQ: VRTX | Vertex Pharmaceuticals Inc. News, Ratings, and Charts

3 Biotech Stocks to Invest In Right Now for Long-Term Gains

With the rapidly growing demand for personalized medicine, innovative solutions, and recent developments like AI in drug discovery, the biotech industry's prospects appear robust. Thus, quality biotech stocks Vertex Pharmaceuticals (VRTX), SIGA Technologies (SIGA), and Gilead Sciences (GILD) could be ideal candidates to buy now. Read more…

NYSE: EPD | Enterprise Products Partners L.P.  News, Ratings, and Charts

3 Energy Stocks Poised for Profits in April

The energy sector is expected to grow significantly due to geopolitical tensions, supply constraints, and rising global demand for natural gas and crude oil. Therefore, fundamentally strong energy stocks Enterprise Products Partners (EPD), Koninklijke Vopak (VOPKY), and VAALCO Energy (EGY) could be worth adding to your portfolio. Read on...

: ALPMY | Astellas Pharma Inc. ADR News, Ratings, and Charts

3 Affordable Pharma Stocks to Buy for Portfolio Gains

The pharmaceutical market is anticipated to grow substantially in the upcoming years, owing to technological innovation and rising demand for personalized medicines. To that end, affordable pharma stocks ACADIA Pharmaceuticals (ACAD), Astellas Pharma (ALPMY), and Spero Therapeutics (SPRO), trading under $20, could be solid buys now. Read on…

NYSE: AMX | America Movil S.A.B. de C.V. ADR Series L News, Ratings, and Charts

3 Telecom Gems for Portfolio Diversification

The telecom industry is poised for significant expansion, driven by rising demand for high-speed connectivity, ongoing innovations, and the rapid growth of 5G networks. Therefore, for portfolio diversification, investors could consider buying fundamentally strong telecom stocks Orange (ORAN), América Móvil (AMX), and KT Corporation (KT). Read more...

NYSE: BOX | Box, Inc.  News, Ratings, and Charts

3 Top-Rated Tech Stock Buys for Value in April

The technology sector is undergoing a notable surge, propelled by increasing digitalization endeavors among businesses and governmental support for technological progress. So, fundamentally sound tech stocks Box Inc. (BOX), Teradata (TDC), and Materialise (MTLS), which seem pretty undervalued, might be ideal buys this month. Continue reading...

: STLA | Stellantis N.V. News, Ratings, and Charts

3 Auto Stocks to Consider Over TSLA in April

Tesla (TSLA) reported a decline in deliveries in the first quarter, and Wall Street expects the company to deliver fewer vehicles than last year. Furthermore, rising competition, slowing EV sales, and stretched valuation make TSLA unattractive from an investment standpoint. Considering these factors, investors could consider buying fundamentally strong auto stocks Blue Bird (BLBD), Rolls-Royce Holdings (RYCEY), and Stellantis (STLA) over Tesla (TSLA). Read more...

NASDAQ: ADSK | Autodesk Inc. News, Ratings, and Charts

Top Software Stocks at the Forefront of Market Gains

The software industry's prospects appear bright due to increasing investments in digital transformation, high demand for advanced software services from various sectors, and the integration of emerging technologies such as generative AI. Therefore, investors could consider buying quality software stocks Autodesk (ADSK), DocuSign (DOCU), and Pegasystems (PEGA) for solid gains. Read more...


NYSE: ABBV | AbbVie Inc.  News, Ratings, and Charts

3 Pharma Stocks Delivering Exciting April Returns

The pharmaceutical industry is expected to grow rapidly due to the ever-rising healthcare needs, increasing demand for innovative medications, and technological advancements. Therefore, fundamentally strong pharmaceutical stocks Dr. Reddy’s (RDY), Teva Pharmaceutical Industries (TEVA), and AbbVie (ABBV) could be worth adding to your portfolio. Read on...

NASDAQ: INCY | Incyte Corp. News, Ratings, and Charts

3 Biotech Gems Poised for April Breakthroughs

The biotechnology industry is expected to grow rapidly due to rising demand for personalized medicines, increased R&D spending, and the adoption of AI in the biopharma market. Hence, quality biotech stocks Incyte (INCY), Jazz Pharmaceuticals (JAZZ), and Exelixis (EXEL) could be poised for breakthroughs this month. Read more…

: GMAB | Genmab A/S ADR News, Ratings, and Charts

3 Biotech Stocks Gaining Altitude and Interest

This year, the biotech industry anticipates a resurgence with increased M&A, FDA approvals, and AI-driven innovations. Given the industry’s rosy prospects, biotech stocks BioMarin Pharmaceutical (BMRN), ANI Pharmaceuticals (ANIP), and Genmab A/S (GMAB), gaining significant altitude and interest, could be ideal buys. Read on...

NYSE: BMY | Bristol-Myers Squibb Co. News, Ratings, and Charts

3 A-Rated Pharma Stocks to Boost Your Bottom Line

The pharmaceutical industry is experiencing rapid growth thanks to healthcare demand, regulatory initiatives, and technological adoption in drug discovery and development. Hence, it could be wise to invest in pharma stocks Ipsen (IPSEY), Bristol-Myers (BMY), and Taro Pharmaceutical (TARO) to drive your bottom line. These stocks are rated A (Strong Buy) in our proprietary rating system. Keep reading…

NYSE: UGP | Ultrapar Participacoes S/A ADR News, Ratings, and Charts

Top 3 Energy Stocks Locking in April Gains

The escalating geopolitical worries, tightened oil supplies, and increased oil consumption have bolstered the energy market. Given this backdrop, quality energy stocks Ultrapar Participações S.A. (UGP), Precision Drilling Corporation (PDS), and Adams Resources & Energy (AE) could be wise portfolio additions for potential gains this month. Read on…

NYSE: C | Citigroup Inc. News, Ratings, and Charts

Is Citigroup (C) Poised for a Rebound After Earnings?

Citigroup (C), the third-biggest U.S. bank by assets, will publish its first-quarter earnings on April 12. C has undergone an overhaul with several key restructuring initiatives across its business over the past year. Is the bank poised for rebound post-earnings? Read on to learn my view...

NYSE: SPY | SPDR S&P 500 ETF Trust News, Ratings, and Charts

Does the Stock Market Have Indigestion?

The easy gains have already rolled in for the S&P 500 (SPY) to new heights. However, signs point to stocks entering a stage of “digestion”. What does that mean? And what does it tell us about investing in stocks the rest of the year? Steve Reitmeister shares his time views in this new market commentary including a preview of this top stocks to outperform. Get the full story below...

NYSE: DNOW | NOW Inc.  News, Ratings, and Charts

3 Hot Energy Stocks Gaining Altitude in April

Geopolitical tensions, increasing global demand for oil and natural gas, supply limitations, and technological innovations are paving the way for robust growth of the energy sector. Hence, top energy stocks such as DNOW (DNOW), Geospace Technologies (GEOS), and Gulf Island Fabrication (GIFI) might be solid investments for April. Read more...

: ET | Energy Transfer LP News, Ratings, and Charts

3 Energy Stock Buys Surging Past Expectations

Rising oil prices due to escalating geopolitical tensions and supply concerns should bode well for the energy sector. So, I think fundamentally solid energy stocks Energy Transfer (ET), Pembina Pipeline (PBA), and Matrix Service (MTRX) might be ideal buys. Read more...

Page generated in 2.5179 seconds.